Company Description Pilot Company is an industry-leading network of travel centers with more than 30,000 team members and over 750 retail and fueling locations in 44 states and six Canadian provinces. Our energy and logistics division ser...
Our Story We’re J.Crew Factory, and we believe shopping should be fun. Our brand is built on creating timeless styles... and collaboration. If this sounds like you, we want to talk. At J.Crew Factory, there are no strangers, only friends you haven’t met yet...
Description : General Summary Primary provides administrative and secretarial support to the daily operations of the department. Secondarily provides backup support to Production Control Clerk. Essential Duties and Responsibilities ...
Our Story We’re J.Crew Factory, and we believe shopping should be fun. Our brand is built on creating timeless styles... and collaboration. If this sounds like you, we want to talk. At J.Crew Factory, there are no strangers, only friends you haven’t met yet...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »